Avoro Capital Advisors LLC Biocryst Pharmaceuticals Inc Call Options Transaction History
Avoro Capital Advisors LLC
- $6.18 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BCRX
# of Institutions
295Shares Held
181MCall Options Held
721KPut Options Held
489K-
Vanguard Group Inc Valley Forge, PA21.7MShares$194 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$179 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.93MShares$80 Million5.64% of portfolio
-
State Street Corp Boston, MA7.81MShares$70 Million0.0% of portfolio
-
Alkeon Capital Management LLC New York, NY7.21MShares$64.6 Million0.11% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.67B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...